MARATTO

article · Cureus

Retrospective Study of Morton’s Neuroma: Clinical, Paraclinical, and Therapeutic Assessment of 10 Cases

20241 citationOpen accessMohamed I University

Abstract

Background Morton's neuroma is a common cause of forefoot pain, typically occurring in the third metatarsal space and characterized by symptomatic nerve compression. This condition often leads to significant functional impairment, affecting weight-bearing activities and limiting appropriate footwear due to pain and discomfort. Objective This study aims to evaluate the outcomes of conservative interventional treatment for Morton's neuroma, specifically focusing on corticosteroid injections. Methodology We reviewed 10 cases of Morton's neuroma in the field of physical medicine and rehabilitation. The average age of the patients was 45 years, with a higher prevalence among females. Diagnoses were confirmed through clinical assessment and ultrasound imaging. Results All 10 patients (100%) received conservative interventional treatment with corticosteroid injections. This approach effectively alleviated symptoms in 9 out of 10 patients (90%). Surgical options were considered only if symptoms did not improve with this treatment. Conclusions All 10 patients (100%) were treated with corticosteroid injections, which alleviated symptoms in 9 out of 10 patients (90%). Surgical options were considered only if this treatment was insufficient. This analysis highlights the effectiveness of this approach as a first-line management strategy for Morton's neuroma.

Research topics

  • Peripheral Nerve Disorders
  • Orthopedic Surgery and Rehabilitation
  • Tendon Structure and Treatment

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.7759/cureus.75968

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.